| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |